RNU6-368P

Across TCGA pan-cancer cohorts, RNU6-368P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU6-368P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-368P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-368P expression acts as an unfavorable survival marker.

STAD are the cancer types where RNU6-368P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.083	0.710	<.001	72	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

RNU6-368P–STAD (DFS)

Open the STAD breakdown →